1. Home
  2. ADAP vs WVVI Comparison

ADAP vs WVVI Comparison

Compare ADAP & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • WVVI
  • Stock Information
  • Founded
  • ADAP 2008
  • WVVI 1983
  • Country
  • ADAP United Kingdom
  • WVVI United States
  • Employees
  • ADAP N/A
  • WVVI N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • WVVI Beverages (Production/Distribution)
  • Sector
  • ADAP Health Care
  • WVVI Consumer Staples
  • Exchange
  • ADAP Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • ADAP 21.3M
  • WVVI 20.4M
  • IPO Year
  • ADAP 2015
  • WVVI N/A
  • Fundamental
  • Price
  • ADAP $0.07
  • WVVI $4.57
  • Analyst Decision
  • ADAP Hold
  • WVVI
  • Analyst Count
  • ADAP 6
  • WVVI 0
  • Target Price
  • ADAP $1.02
  • WVVI N/A
  • AVG Volume (30 Days)
  • ADAP 63.5M
  • WVVI 3.7K
  • Earning Date
  • ADAP 11-12-2025
  • WVVI 11-11-2025
  • Dividend Yield
  • ADAP N/A
  • WVVI N/A
  • EPS Growth
  • ADAP N/A
  • WVVI N/A
  • EPS
  • ADAP N/A
  • WVVI N/A
  • Revenue
  • ADAP $65,084,999.00
  • WVVI $38,384,350.00
  • Revenue This Year
  • ADAP N/A
  • WVVI N/A
  • Revenue Next Year
  • ADAP $52.35
  • WVVI N/A
  • P/E Ratio
  • ADAP N/A
  • WVVI N/A
  • Revenue Growth
  • ADAP N/A
  • WVVI N/A
  • 52 Week Low
  • ADAP $0.04
  • WVVI $3.17
  • 52 Week High
  • ADAP $1.12
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 44.99
  • WVVI 46.63
  • Support Level
  • ADAP $0.06
  • WVVI $4.80
  • Resistance Level
  • ADAP $0.07
  • WVVI $5.09
  • Average True Range (ATR)
  • ADAP 0.01
  • WVVI 0.21
  • MACD
  • ADAP 0.01
  • WVVI 0.05
  • Stochastic Oscillator
  • ADAP 88.67
  • WVVI 33.31

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: